US EditionPublished • loading... • Updated
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 38.53% Upside Potential for Investors
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 38.53% Upside Potential for Investors
Bio-Rad Laboratories, Inc. (NYSE: BIO), a veteran in the healthcare sector, is a prominent player in the medical devices industry. Founded in 1952 and headquartered in Hercules, California, the company specializes in life science research and clinical diagnostic products. With a market capitalization of $6.21 billion, Bio-Rad serves a global clientele, including the United States, Europe, Asia, Canada, and Latin America. The current stock price …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
